We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ONDANSETRON-AFT (AFT Pharmaceuticals Pty Ltd)
Product name
ONDANSETRON-AFT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
249 working days (255)
Active ingredients
ondansetron
Registration type
New generic medicine
Indication
ONDANSETRON-AFT (solution for injection) is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ONDANSETRON-AFT is also indicated for the prevention and treatment of post-operative nausea and vomiting.